CALC: Continues Auxora Dosing
CalciMedica receives no FDA comments on its Phase 2 KOURAGE trial submission, allowing continued patient dosing with Auxora
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.